Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
29.83
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
Texas Sues Pfizer For "Misrepresenting COVID-19 Vaccine Efficacy" And "Conspiring To Censor Public Discourse"
November 30, 2023
The Texas attorney general is suing pharmaceutical giant Pfizer for misrepresenting the effectiveness of the company's Covid-19
Via
Talk Markets
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
ImmunoGen Stock Nearly Doubled On Thursday: What Happened?
November 30, 2023
Shares of ImmunoGen Inc. close to doubled this morning after AbbVie Inc. said it will buy the cancer therapies company for $10.1 billion.
Via
Talk Markets
Billionaire Favorites: 3 Ultra-High Yield Stocks the Elite Love
November 30, 2023
Buying stocks simple for their high dividend yields is risky but these are three stocks the elite love regardless.
Via
InvestorPlace
How To Make $500 A Month With Pfizer Stock
November 30, 2023
Pfizer Inc. (NYSE: PFE) shares closed higher on Wednesday.
Via
Benzinga
Loser Stocks: Buy More, Hold Or Sell?
November 29, 2023
Many investors bought during the exciting go-go days of the pandemic, as stocks surged to new all-time highs. But many stocks, especially the technology growth stocks, plunged in 2022.
Via
Talk Markets
3 Synthetic Biology Stocks Likely to Mint New Millionaires
November 29, 2023
Synthetic biology stocks are strongly worth considering for several reasons, particularly these three stocks.
Via
InvestorPlace
How Is The Market Feeling About Pfizer?
November 27, 2023
Via
Benzinga
Is Pfizer Stock a Buy Now?
November 24, 2023
The company keeps falling out of favor with the market.
Via
The Motley Fool
Companies That Grow Through Acquisitions: Pros And Cons
November 29, 2023
We hit one of dividend growth investors’ favorite business model types: growth through acquisitions. While it often rhymes with dividend growth, there are pros and cons to consider.
Via
Talk Markets
Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's
November 28, 2023
Merck & Co Inc (NYSE: MRK) released results from the STRIDE-3 Phase 3 trial evaluating V116, the company's investigational 21-valent
Via
Benzinga
3 Top-Rated Value Stocks That Analysts Are Loving Now
November 27, 2023
Stuff your stockings with these top-rated value stocks. Analysts are feeling good about this value stocks heading into 2024.
Via
InvestorPlace
Biotech And Healthcare Portfolio Playbook For December 2023/24
November 27, 2023
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January.
Via
Talk Markets
Why Biodexa Pharmaceuticals Stock (BDRX) Is Skyrocketing
November 27, 2023
Biodexa Pharmaceuticals PLC-ADR (NASDAQ: BDRX) shares are trading higher by 60% to $4.48 Monday morning after the company announced it has acquired the rights to tolimidone, an experimental drug...
Via
Benzinga
Uncovering Dividend Opportunities with NYSE:PFE.
November 23, 2023
Balancing Dividends and Fundamentals: The Case of PFIZER INC (NYSE:PFE).
Via
Chartmill
Behind the Scenes of Pfizer's Latest Options Trends
November 20, 2023
Via
Benzinga
18 Analysts Have This to Say About Pfizer
November 20, 2023
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
November 27, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
November 26, 2023
An upcoming mid-stage readout may not spark a trend reversal in the big pharma's shares.
Via
The Motley Fool
These Three Biotech Stocks Are Trading At A Discount
November 23, 2023
Investors exposed to the biotech sector have seen mixed results this year.
Via
Talk Markets
Olema Stock Has Soared 551% This Year. Its CEO Thinks It's Still Undervalued.
November 22, 2023
The company is working on treatments for breast cancer in a market worth $15 billion, according to the CEO.
Via
Investor's Business Daily
2 Stocks You'll Be Grateful You Bought at These Bargain Prices
November 22, 2023
These companies are leaders in their industries.
Via
The Motley Fool
Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today?
November 21, 2023
Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent owned by Moderna is invalid, marking a victory for Pfizer Inc (NYSE: PFE) /
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
November 21, 2023
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,...
Via
Benzinga
Topics
ETFs
Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now
November 21, 2023
Investors have favored an exciting billion-dollar opportunity at Eli Lilly.
Via
The Motley Fool
Dual Powerhouses: 7 Dividend Stocks Marrying High Yield With High Growth
November 20, 2023
Although you can’t usually have your cake and eat it too, these compelling high-yield dividend growth stocks may prove otherwise.
Via
InvestorPlace
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
November 20, 2023
Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF)
Via
Benzinga
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details
November 20, 2023
Bayer AG (OTC: BAYRY) (OTC: BAYZF)
Via
Benzinga
The 7 Most Undervalued Sleeper Stocks to Buy Now: November 2023
November 19, 2023
Here are just a few of the most undervalued sleeper stocks investors may want to consider heading into the new year.
Via
InvestorPlace
What's Going On With Penny Stock AgeX Therapeutics?
November 17, 2023
Serina Therapeutics Inc, a privately held, clinical-stage biotechnology company, entered into a License Agreement under which Pfizer Inc (NYSE: PFE) will license, on a non-exclusive basis, Serina's
Via
Benzinga
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
November 17, 2023
Biotech companies are edging closer to finding the answers behind Alzheimer's disease.
Via
Investor's Business Daily
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.